Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 24, 2024

BUY
$1.08 - $1.85 $1,944 - $3,330
1,800 New
1,800 $2.56 Million
Q2 2022

Oct 13, 2023

BUY
$1.15 - $2.53 $919 - $2,023
800 Added 80.0%
1,800 $2.41 Million
Q1 2022

Oct 13, 2023

BUY
$1.91 - $3.98 $1,910 - $3,980
1,000 New
1,000 $2.11 Million

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $231M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Wfa Asset Management Corp Portfolio

Follow Wfa Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wfa Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Wfa Asset Management Corp with notifications on news.